The result wasSerohub, a platform to accelerate research about the seroprevalence of SARS-CoV-2. We delivered a platform to enable researchers, government, and industry partners to contribute knowledge and tools and ultimately improve evidence-based decision-making on COVID-19.
The overall approach was to support the increased use of data-driven approaches for infection research and drive greater collaboration. The project had four primary aims: be a community space for researchers, allow for critical appraisal of diagnostic trials, host study-related documents, and be a cloud-based, meta-analysis platform.
- Build a centralised platform where researchers can share studies, publications, and data easily
- Incorporate four key platform elements: community, trial summary, document, and meta-analysis
- Train and support staff in adopting and maintaining the platform to ensure long-term sustainability.
- Align with research, management, and technical teams on data infrastructure and content
- Built a sharing facility using the Netlify CMS to allow easy study management
- Used GitHub to enable greater levels of collaboration in a cost-effective way
- Delivered a general public website and a service environment for researchers
- Trained and onboarded staff to use and maintain the platform effectively ensuring scalability.
- Serohub platform launched
- 105 Publications uploaded
- 6 major research studies shared
- Collaborations across 3 continents.
Serohub platform serohub.net/en/